Literature DB >> 16906381

Tacrolimus treatment for refractory lupus cystitis.

Hiroshi Maruoka1, Seiyo Honda, Masaaki Takeo, Takeharu Koga, Takaaki Fukuda, Hisamichi Aizawa.   

Abstract

A 23-year-old woman presented with recurrence of lupus cystitis, which had been in remission under daily administration of a single corticosteroid over a period of 8 years. She was treated with increased doses of corticosteroid and immunosuppressants, i.e., cyclosporin, cyclophosphamide, azathioprine, and salazosulfapyridine, but the cystitis remained active. Since her condition became critical by the complication of intestinal pseudo-obstruction, tacrolimus was administered. This agent induced a remission promptly without significant adverse events in this patient, suggesting an efficacy to lupus cystitis refractory to corticosteroid and other immunosuppressants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906381     DOI: 10.1007/s10165-006-0494-2

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  6 in total

1.  Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus.

Authors:  Katsuya Suzuki; Hideto Kameda; Koichi Amano; Hayato Nagasawa; Hirofumi Takei; Eiko Nishi; Ayumi Okuyama; Kensei Tsuzaka; Tsutomu Takeuchi
Journal:  Rheumatol Int       Date:  2010-02-19       Impact factor: 2.631

2.  Intestinal pseudo-obstruction in patients with systemic lupus erythematosus: a real diagnostic challenge.

Authors:  Carlos Alberto García López; Fernando Laredo-Sánchez; José Malagón-Rangel; Miguel G Flores-Padilla; Haiko Nellen-Hummel
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 3.  Intestinal pseudo-obstruction in systemic lupus erythematosus: a case report and review of the literature.

Authors:  Jian-Lin Wang; Gang Liu; Tong Liu; Jiang-Peng Wei
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

4.  The use of tacrolimus for recurrent lupus enteritis: a case report.

Authors:  Tsuyoshi Shirai; Yasuhiko Hirabayashi; Ryu Watanabe; Yumi Tajima; Hiroshi Fujii; Naruhiko Takasawa; Tomonori Ishii; Hideo Harigae
Journal:  J Med Case Rep       Date:  2010-05-24

5.  Influence of renal complications on the efficacy and adverse events of tacrolimus combination therapy in patients with systemic lupus erythematosus (SLE) during a maintenance phase: a single-centre, prospective study.

Authors:  Sho Ishii; Yusuke Miwa; Kumiko Otsuka; Shinichiro Nishimi; Airi Nishimi; Mayu Saito; Yoko Miura; Nao Oguro; Takahiro Tokunaga; Ryo Takahashi; Tsuyoshi Kasama
Journal:  Lupus Sci Med       Date:  2015-05-29

Review 6.  Lupus Cystitis, From Myth to Reality: A Narrative Review.

Authors:  Juan Camilo Santacruz; Sandra Pulido; Angelo Arzuaga; Marta Juliana Mantilla; John Londono
Journal:  Cureus       Date:  2021-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.